Cargando…
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial
Breast cancer risk reduction has been validated by large-scale clinical trials, but uptake remains low. A risk communication tool could provide personalized risk-reduction information for high-risk women. A low-literacy-friendly, visual, and personalized tool was designed as part of the Women Inform...
Autores principales: | Keane, Holly, Huilgol, Yash S., Shieh, Yiwey, Tice, Jeffrey A., Belkora, Jeff, Sepucha, Karen, Shibley, W. Patrick, Wang, Tianyi, Che, Mandy, Goodman, Deborah, Ozanne, Elissa, Fiscalini, Allison Stover, Esserman, Laura J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211836/ https://www.ncbi.nlm.nih.gov/pubmed/34140528 http://dx.doi.org/10.1038/s41523-021-00288-8 |
Ejemplares similares
-
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study
por: Wang, Tianyi, et al.
Publicado: (2023) -
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry
por: Huilgol, Yash S., et al.
Publicado: (2021) -
Training community resource center and clinic personnel to prompt patients in listing questions for doctors: Follow-up interviews about barriers and facilitators to the implementation of consultation planning
por: Belkora, Jeffrey, et al.
Publicado: (2008) -
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches
por: Eklund, Martin, et al.
Publicado: (2019) -
Response to Carter et al.
por: Eklund, Martin, et al.
Publicado: (2020)